One recent PROSPERO-registered network meta-analysis of PDE5 inhibitors in men with SCI-related erectile dysfunction (Tienforti et al. [56]) was judged to have no critical flaws and was rated at the boundary between high and moderate confidence. The gene discussed is PDE5A; the disease is erectile dysfunction.